Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 134


Improvement of upper trunk posture during walking in hemiplegic patients after injections of botulinum toxin into the arm.

Hefter H, Rosenthal D.

Clin Biomech (Bristol, Avon). 2017 Mar;43:15-22. doi: 10.1016/j.clinbiomech.2017.01.018. Epub 2017 Jan 26.


Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.

Jarius S, Ringelstein M, Haas J, Serysheva II, Komorowski L, Fechner K, Wandinger KP, Albrecht P, Hefter H, Moser A, Neuen-Jacob E, Hartung HP, Wildemann B, Aktas O.

J Neuroinflammation. 2016 Oct 24;13(1):278.


Increased volume and impaired function: the role of the basal ganglia in writer's cramp.

Zeuner KE, Knutzen A, Granert O, Götz J, Wolff S, Jansen O, Dressler D, Hefter H, Hallett M, Deuschl G, van Eimeren T, Witt K.

Brain Behav. 2015 Feb;5(2):e00301. doi: 10.1002/brb3.301. Epub 2014 Dec 24.


Post-operative quality of life in children with severe perthes disease: differences to matched controls and correlation with clinical function.

Palmen NK, Zilkens C, Rosenthal D, Krauspe R, Hefter H, Westhoff B.

Orthop Rev (Pavia). 2014 Nov 10;6(4):5567. doi: 10.4081/or.2014.5567. eCollection 2014 Oct 27.


Hepatobiliary malignancies in Wilson disease.

Pfeiffenberger J, Mogler C, Gotthardt DN, Schulze-Bergkamen H, Litwin T, Reuner U, Hefter H, Huster D, Schemmer P, Członkowska A, Schirmacher P, Stremmel W, Cassiman D, Weiss KH.

Liver Int. 2015 May;35(5):1615-22. doi: 10.1111/liv.12727. Epub 2014 Nov 23.


Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.

Jost WH, Hefter H, Reissig A, Kollewe K, Wissel J.

J Neurol Sci. 2014 Feb 15;337(1-2):86-90. doi: 10.1016/j.jns.2013.11.022. Epub 2013 Nov 22.


Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis.

Hefter H, Spiess C, Rosenthal D.

J Neural Transm (Vienna). 2014 May;121(5):513-9. doi: 10.1007/s00702-013-1127-5. Epub 2013 Dec 6.


An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport).

Hefter H, Benecke R, Erbguth F, Jost W, Reichel G, Wissel J.

BMJ Open. 2013 Apr 18;3(4). pii: e001853. doi: 10.1136/bmjopen-2012-001853. Print 2013.


Efficacy and safety of oral chelators in treatment of patients with Wilson disease.

Weiss KH, Thurik F, Gotthardt DN, Schäfer M, Teufel U, Wiegand F, Merle U, Ferenci-Foerster D, Maieron A, Stauber R, Zoller H, Schmidt HH, Reuner U, Hefter H, Trocello JM, Houwen RH, Ferenci P, Stremmel W; EUROWILSON Consortium.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):1028-35.e1-2. doi: 10.1016/j.cgh.2013.03.012. Epub 2013 Mar 28.


Retinal neurodegeneration in Wilson's disease revealed by spectral domain optical coherence tomography.

Albrecht P, Müller AK, Ringelstein M, Finis D, Geerling G, Cohn E, Aktas O, Hartung HP, Hefter H, Methner A.

PLoS One. 2012;7(11):e49825. doi: 10.1371/journal.pone.0049825. Epub 2012 Nov 16.


Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy.

Jost WH, Hefter H, Stenner A, Reichel G.

J Neural Transm (Vienna). 2013 Mar;120(3):487-96. doi: 10.1007/s00702-012-0887-7. Epub 2012 Aug 17. Review.


A case of relapsing-remitting neuroborreliosis? Challenges in the differential diagnosis of recurrent myelitis.

Albrecht P, Henke N, Lehmann HC, Macht S, Hefter H, Goebels N, Mackenzie C, Rupprecht TA, Fingerle V, Hartung HP, Methner A.

Case Rep Neurol. 2012 Jan;4(1):47-53. doi: 10.1159/000337223. Epub 2012 Mar 14.


Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?

Hefter H, Jost WH, Reissig A, Zakine B, Bakheit AM, Wissel J.

Int J Rehabil Res. 2012 Sep;35(3):227-33. doi: 10.1097/MRR.0b013e328353e3d4.


A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis.

Hefter H, Kupsch A, Müngersdorf M, Paus S, Stenner A, Jost W; Dysport Cervical Dystonia Study Group.

BMJ Open. 2011 Jan 1;1(2):e000196. doi: 10.1136/bmjopen-2011-000196.


Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?

Benecke R, Heinze A, Reichel G, Hefter H, Göbel H; Dysport myofascial pain study group.

Pain Med. 2011 Nov;12(11):1607-14. doi: 10.1111/j.1526-4637.2011.01163.x. Epub 2011 Jun 21.


[Superficial siderosis of the central nervous system in a patient with hemochromatosis and Wilson's disease].

Warnke C, Andersen K, Hartung HP, Hefter H.

Dtsch Med Wochenschr. 2011 Apr;136(14):721-4. doi: 10.1055/s-0031-1274572. Epub 2011 Mar 29. German.


Evaluation of the symptomatic treatment of residual neurological symptoms in Wilson disease.

Hölscher S, Leinweber B, Hefter H, Reuner U, Günther P, Weiss KH, Oertel WH, Möller JC.

Eur Neurol. 2010;64(2):83-7. doi: 10.1159/000316066. Epub 2010 Jul 6.


Phase relations between rhythmical movements and breathing in wind instrument players.

Ebert D, Georgas E, Rosenthal D, Wibowo C, Massing T, Barth T, Hefter H.

Adv Exp Med Biol. 2010;669:231-4. doi: 10.1007/978-1-4419-5692-7_46.


The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey.

Bakheit AM, Zakine B, Maisonobe P, Aymard C, Fhedoroff K, Hefter H, Jacinto J, Jost WH, Molteni F, Stam H, Turner-Stokes L, Wissel J.

Int J Rehabil Res. 2010 Sep;33(3):199-204. doi: 10.1097/MRR.0b013e328332f5e0.


Supplemental Content

Loading ...
Support Center